Programme at a Glance | EASD

You are here

Programme at a Glance

Non-commercial satellite symposia on the occasion of the 53rd EASD Annual Meeting:

Date	Time	Cézanne Hall	Edison Hall	Verne Hall	Minot Hall
Sunday, 10 September 2017	13:30 - 17:30	The REMOVAL trial	IDF Europe	PCDE & DESG	From the cornea to the heart
Monday, 11 September 2017	14:30 - 17:00				EURADIA Symposium

Commercial satellite symposia on the occasion of the 53rd EASD Annual Meeting (links will open in a new window):

Scientific programme of the 53rd EASD Annual Meeting:

Tuesday, 12 September 2017

	Roma Hall	Lawrence Hall	Puccini Hall	Fitzgerald Hall	Fröbe Hall	Dürrenmatt Hall	Minot Hall
08:30 - 08:45	Opening Ceremony
08:45 - 09:15	Presidential Address
09:15 - 10:00	49th Claude Bernard Lecture
10:15 - 11:45	OP 1	OP 2	OP 3	OP 4	OP 5	OP 6
12:00 - 13:00	Poster Event A
13:15 - 14:15	Poster Event B
14:30 - 16:00	OP 7	OP 8	OP 9	OP 10	OP 11	OP 12
16:15 - 17:15	32nd Camillo Golgi Lecture	11th Albert Renold Lecture
17:30 - 18:30							EASD General Assembly Agenda for GA 2017 Minutes from GA 2016

Wednesday, 13 September 2017

	Roma Hall	Lawrence Hall	Puccini Hall	Fitzgerald Hall	Fröbe Hall	Dürrenmatt Hall	Cézanne Hall
08:30 - 10:00	An emerging and innovative therapeutic approach in type 1 diabetes with dual SGLT1 and SGLT2 inhibition: the Sotagliflozin Clinical Program	East-West Forum: diabetes outcome trends	EASD/ESC Symposium: Cardiovascular complications of diabetes: hot topics	Intergenerational transmission of obesity and diabetes: Is the fog being cleared?	The beta cell in type 2 diabetes: what are the changes and are they reversible?	EASD/ADA Symposium: Molecular transducers of metabolic benefits of exercise	Effects on the incidence of cardiovascular events of the add-on of pioglitazone as compared with a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin: the TOSCA.IT study
10:15 - 11:45	OP 13	OP 14	OP 15	OP 16	OP 17	OP 18
12:00 - 13:00	Poster Event C
13:15 - 14:15	Poster Event D
14:30 - 16:00	OP 19	OP 20	OP 21	OP 22	OP 23	OP 24
16:15 - 17:15	EASD-Novo Nordisk Foundation Diabetes Prize for Excellence
17:30 - 18:30	Acarbose Cardiovascular Evaluation (ACE): primary results	Dicarbonyl stress: from the bench to the clinic	Diabetes, obesity, their treatment and cancer risk: smoke or fire?	Metformin diamond jubilee	Cognitive impairment and Alzheimer's disease in type 2 diabetes patient: from basic science to treatment	EASD/JDRF Symposium: Generation of stem cell-derived beta cells from type 1 diabetes patients

Thursday, 14 September 2017

	Roma Hall	Lawrence Hall	Puccini Hall	Fitzgerald Hall	Fröbe Hall	Dürrenmatt Hall	Cézanne Hall
08:30 - 10:00	Role of alirocumab in lipid management of individuals with type 1 and type 2 diabetes at high CV risk: ODYSSEY DM program	Neuroprotection: a new target for treating diabetic retinopathy	Hypoglycaemia revisited	Michael Berger debate: What do we have in the future of type 2 diabetes prediction and prevention?	Central regulation of glucose metabolism	Metabolism rocks around the clock	SGLT2 inhibitors: novel therapies for type 1 diabetes
10:15 - 11:45	OP 25	OP 26	OP 27	OP 28	OP 29	OP 30
12:00 - 13:00	Poster Event E
13:15 - 14:15	Poster Event F
14:30 - 16:00	OP 31	OP 32	OP 33	OP 34	OP 35	OP 36
16:15 - 17:00	Induction of Honorary Members 52nd Minkowski Lecture
17:15 - 18:15	EXenatide Study of Cardiovascular Event Lowering (EXSCEL): primary results	Advances in infusion sets and insulin pumps	Calorie restriction: How does it affect metabolic functions?	New targets for prevention of diabetes complications	Immune modulation in the treatment of diabetes	Precision medicine in diabetes: How close are we?

Friday, 15 September 2017

	Roma Hall	Lawrence Hall	Puccini Hall	Fitzgerald Hall	Fröbe Hall	Dürrenmatt Hall	Cézanne Hall
08:30 - 09:30	Insulin degludec vs glargine cardiovascular safety in T2D: the DEVOTE study	Prevention of obesity-related pregnancy complications	Diabetes in primary care in Europe	Obesity as a key driver for diabetes	Genome editing principle and practice: Is there opportunity for diabetes?	Diabetes and alpha cell function	Evolocumab in diabetes and diabetes risk: novelties from the FOURIER study
09:45 - 10:45	OP 37	OP 38	OP 39	OP 40	OP 41	OP 42	Continuous Glucose Monitoring before and during pregnancy in women with type 1 diabetes: results from CONCEPTT; a multicentre multinational randomised controlled trial
11:00 - 12:00	OP 43	OP 44	OP 45	OP 46	OP 47	OP 48	J-DOIT3: a multifactorial intervention trial for prevention of macrovascular complications and mortality
12:15 - 13:45	CANagliflozin cardioVascular Assessment Study (CANVAS)	Is the gut the answer to it all?	The paradox of metabolically healthy obesity: Do we need better phenotyping?	Organ specific vascular permeability in diabetes	Adipose tissue, the link between insulin resistance and comorbidities?	EASD/ERA-EDTA Symposium: New insights in diabetes nephropathy	Rising Star Symposium
13:45 - 13:55							Rising Star Symposium

Please note: The programme may be subject to change